Home › Funds › RTW INVESTMENTS, LP › VRDN

RTW INVESTMENTS, LP position in VRDN

VIRIDIAN THERAPEUTICS INC · Health Care

RTW INVESTMENTS, LP reported holding 4,977,832 shares of VRDN (VIRIDIAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$102.0M, representing 1.03% of its reported portfolio and ranking #36 among its reported holdings. RTW INVESTMENTS, LP has disclosed VRDN holdings in 4 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)4.98M sh
Reported value held$102.03M
Portfolio Weight1.03%
First reportedQ4 2023
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's VRDN position evolved

RTW INVESTMENTS, LP first disclosed a stake in VRDN in Q4 2023 at 605,816 shares (US$13.2M). The position peaked in Q3 2026 at 4,977,832 shares, worth US$102.0M. Across 4 filings, RTW INVESTMENTS, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 4,977,832 shares valued at US$102.0M.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 605.82K $13.19M New
Q1 2024 605.82K $10.61M Hold
Q2 2024 605.82K $7.88M Hold
Q3 2026 4.98M $102.03M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRDN and 13F data

VRDN (VIRIDIAN THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in VRDN — the largest reported positions include Paradigm Biocapital Advisors LP (US$227.1M), Kynam Capital Management, LP (US$126.6M), Bellevue Group AG (US$123.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRDN

All VRDN fund holders →

FAQ

How long has RTW INVESTMENTS, LP held VRDN?

RTW INVESTMENTS, LP has disclosed VRDN holdings in 4 of the last 12 reported quarters, going back to Q4 2023.

What is RTW INVESTMENTS, LP's current position in VRDN?

As of Q3 2026, RTW INVESTMENTS, LP holds 4.98M shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $102.03M, representing 1.03% of its reported portfolio and ranking #36.

Has RTW INVESTMENTS, LP been buying or selling VRDN?

In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP newly opened its position in VRDN. The position peaked in Q3 2026 at 4.98M shares.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, Bellevue Group AG, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.